Leonteq Securities AG has filed a Form 13F-HR with the U.S. Securities and Exchange Commission, disclosing its equity securities portfolio as of the close of business on September 30, 2026. The filing, submitted on October 29, 2026, lists the company's total assets under management as $2,441,952,700.
The report identifies Vincenzo Fattorusso as the Head of Network Management responsible for the disclosure. The filing details a portfolio of over 1,000 individual equity positions, with a significant concentration in large-capitalization technology and healthcare companies. Notable holdings include Apple Inc., with 69,201,556 shares; Advanced Micro Devices Inc., holding 46,187,880 shares; and Alibaba Group Holding Ltd., with 11,099,757 shares.
The portfolio also includes substantial positions in biotechnology and pharmaceutical firms, such as BioNTech SE (1,163,675 shares), AbbVie Inc. (1,707,398 shares), and Amgen Inc. (722,464 shares). Additionally, the filing lists significant exposure to industrial and financial sectors, including American Tower Corporation, BlackRock Inc., and Bank of America Corp.
The report indicates that all positions are held in a Sole voting capacity, with no shared voting or dispositive rights reported for the listed securities.
